series-c-plus
Stage
3
Investors
About
eGenesis is a biotechnology company utilizing multiplex gene editing and genome engineering to develop human-compatible organs through xenotransplantation, aiming to eliminate organ transplant waitlists.
Explore eGenesis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.